LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has introduced the aPAP ClearPath Dried Blood Spot (DBS) Test in the United States ...
SINGAPORE'S DBS GROUP TO LAUNCH U.S. DOLLAR SENIOR BONDS OF 3-YEAR FIXED-RATE AND FLOATING-RATE TRANCHES AND 5-YEAR FLOATING-RATE TRANCHE - TERM SHEET * PROCEEDS WILL BE USED FOR GENERAL BUSINESS ...
SMALL and medium-sized enterprises (SMEs) banking with DBS can now secure their preferred foreign exchange rates for five ...
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
OVER the next two years, some 500 small to medium-sized manufacturers can get help to go green under a new memorandum of ...
DBS launched DBS SecureFX to enable SMEs and corporate clients in Singapore to lock in foreign exchange rates for up to one ...
9d
News-Medical.Net on MSNMedtronic receives FDA approval for BrainSense Adaptive DBS technologyFor the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...
today announced the launch of its next generation technology for dried blood spot (DBS) sample collection. The novel collection system combines Tasso’s new Tile™-T20 dried whole blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results